AEGON ASSET MANAGEMENT UK Plc Has $107.24 Million Holdings in CME Group Inc. $CME

AEGON ASSET MANAGEMENT UK Plc grew its position in shares of CME Group Inc. (NASDAQ:CME) by 25.2% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 362,908 shares of the financial services provider’s stock after buying an additional 73,125 shares during the quarter. CME Group accounts for approximately 1.4% of AEGON ASSET MANAGEMENT UK Plc’s investment portfolio, making the stock its 15th largest holding. AEGON ASSET MANAGEMENT UK Plc’s holdings in CME Group were worth $107,237,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. Empowered Funds LLC raised its stake in shares of CME Group by 11.5% in the first quarter. Empowered Funds LLC now owns 10,027 shares of the financial services provider’s stock valued at $2,660,000 after acquiring an additional 1,037 shares during the last quarter. Marshall Wace LLP increased its holdings in CME Group by 103.1% during the 2nd quarter. Marshall Wace LLP now owns 3,692 shares of the financial services provider’s stock valued at $1,018,000 after purchasing an additional 121,707 shares in the last quarter. Federated Hermes Inc. increased its holdings in CME Group by 1,325.2% during the 2nd quarter. Federated Hermes Inc. now owns 23,572 shares of the financial services provider’s stock valued at $6,497,000 after purchasing an additional 21,918 shares in the last quarter. Nebula Research & Development LLC acquired a new stake in CME Group during the 2nd quarter valued at $992,000. Finally, The Manufacturers Life Insurance Company raised its position in CME Group by 2.6% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 287,876 shares of the financial services provider’s stock valued at $79,344,000 after purchasing an additional 7,397 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

More CME Group News

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME continues to be highlighted as a dividend and value stock, with analysts noting its strong capital returns, electronic trading growth, and global product expansion could support a long-term rebound. Article Title
• Positive Sentiment: One market note said CME may be undervalued after the CEO succession announcement, suggesting the stock could have upside if investors view the leadership transition as orderly. Article Title
• Neutral Sentiment: CME named longtime finance chief Julie Winkler as its next CEO, while Terry Duffy will step into an executive chairman role; the move appears planned and may reduce uncertainty, but it also marks a major leadership change. Article Title
• Neutral Sentiment: The company is also taking legal action against the CFTC over approval of perpetual crypto futures, arguing the products should be treated as swaps rather than futures. The case could affect CME’s role in crypto derivatives, but the financial impact is still uncertain. Article Title
• Negative Sentiment: Goldman Sachs kept a Sell rating on CME and trimmed its price target, citing leadership transition risk and regulatory uncertainty, which may be weighing on sentiment. Article Title

Insider Transactions at CME Group

In other CME Group news, insider Hilda Harris Piell sold 5,753 shares of the company’s stock in a transaction dated Monday, May 18th. The shares were sold at an average price of $304.63, for a total transaction of $1,752,536.39. Following the transaction, the insider directly owned 27,702 shares in the company, valued at approximately $8,438,860.26. This represents a 17.20% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Terrence A. Duffy sold 35,000 shares of the firm’s stock in a transaction dated Friday, May 15th. The shares were sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the completion of the transaction, the chief executive officer directly owned 55,630 shares in the company, valued at $16,606,111.30. This trade represents a 38.62% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.30% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

CME has been the topic of a number of recent analyst reports. Weiss Ratings lowered CME Group from a “buy (a-)” rating to a “buy (b+)” rating in a research note on Thursday, June 11th. Erste Group Bank lowered CME Group from a “buy” rating to a “hold” rating in a research note on Friday, June 5th. Rothschild & Co Redburn upgraded shares of CME Group from a “neutral” rating to a “buy” rating and upped their price target for the stock from $316.00 to $323.00 in a research report on Thursday, June 11th. Jefferies Financial Group decreased their price objective on shares of CME Group from $356.00 to $349.00 and set a “buy” rating on the stock in a report on Thursday, April 9th. Finally, Barclays lowered their price objective on shares of CME Group from $343.00 to $316.00 and set an “equal weight” rating for the company in a research report on Thursday, April 23rd. Twelve research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $305.18.

CME Group Price Performance

NASDAQ:CME opened at $246.38 on Friday. The company has a market cap of $89.28 billion, a price-to-earnings ratio of 21.02, a P/E/G ratio of 2.75 and a beta of 0.21. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The stock’s fifty day moving average price is $279.61 and its two-hundred day moving average price is $287.21. CME Group Inc. has a 52-week low of $244.56 and a 52-week high of $329.16.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 EPS for the quarter, beating the consensus estimate of $3.11 by $0.25. The company had revenue of $1.88 billion during the quarter, compared to analysts’ expectations of $1.77 billion. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The business’s revenue for the quarter was up 14.5% on a year-over-year basis. During the same period last year, the firm earned $2.80 EPS. On average, analysts anticipate that CME Group Inc. will post 12.28 EPS for the current year.

CME Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Tuesday, June 9th will be issued a $1.30 dividend. The ex-dividend date is Tuesday, June 9th. This represents a $5.20 annualized dividend and a yield of 2.1%. CME Group’s dividend payout ratio (DPR) is currently 44.37%.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.